weldonbme.org

Friday, January 19, 2007

First BME Student Remembers

Dr. Stephen Grubbs, MD, was the first student of Dr. Leslie A. Geddes when biomedical engineering began at Purdue in 1974.  In this podcast, he talks about how he came to be that student, Dr. Geddes, and the changes seen in the program.  You can hear it as an M4a file or as an MP3 file.  As always, suggestions and comments on improvement, or for topics of future podcasts, are welcome. 

Friday, June 02, 2006

Three From Weldon Named AIMBE Fellows

Greg Ayers, John DeFord, and Ben Hillberry have been named to the College of Fellows of the American Institute for Medical and Biological Engineering. 

The College of Fellows consists of about 1,000 individuals who are the outstanding bioengineers in academia, industry and government. These leaders in the field have distinguished themselves through their contributions in research, industrial practice, and/or education. The Fellows are inducted at AIMBE’s annual event, held each spring in Washington, D.C.

Dr. Gregory M. Ayers has held critical leadership roles with a number of successful medical device start-up companies. These roles range from the scientific through clinical affairs to chief executive officer. As Vice President of Clinical Affairs at InControl, Inc. he led the pre-clinical and clinical evaluations of the first implantable atrial defibrillator. To these efforts he brought a wealth of physiologic and medical expertise in cardiac electrophysiology and rhythm management. Most recently, he has led CryoCor, Inc. as a pioneer in the development of hypothermic ablation technologies for arrhythmia therapy. He is one of the few non-practicing cardiologists elected as a Fellow of the American Academy of Cardiology for his significant and practical contributions to this technology-based field. He received his BS in Interdisciplinary Engineering (Biomedical Engineering) from Purdue in 1985, his PhD in Veterinary Physiology and Pharmacology from Purdue University in 1989, and his MD from Indiana University in 1992.

At C.R. Bard, Inc., Dr. John A. DeFord currently oversees Bard’s research and new product development group in the fields of vascular, urology, oncology, and surgical specialty products. Prior to joining Bard, he was the Managing Director of Early Stage Partners, a Midwest venture capital fund, where he was responsible for early stage life science investments. He led the founding and served on the Board of Directors of several life science and technology companies. At Cook Inc., Dr. DeFord spearheaded the development of several medical device divisions, including Cook Neurosurgical, Cook Radiation Oncology, and Cook Endovascular. The latter division created the worldwide product development, regulatory, sales, marketing, and operational teams which introduced the very successful Zenith™ family of endovascular grafts for the treatment of abdominal, iliac, and thoracic aneurysms. As director of the Diagnostic and Interventional Products division, he led the development of significant device innovations such as drug coated coronary and peripheral stents, endovascular grafts, biomaterial/device combinational products, antimicrobial implants, and other vascular and non-vascular products. His direction of the company’s business development activities significantly strengthened their position as a leader in the medical device industry. His vision and leadership continue to have a major impact on the development and translation of life-enhancing medical technologies.

For almost 40 years, Professor Ben M. Hillberry has been a research and education leader in the field of biomechanics. He has conducted important studies to identify the physical mechanisms contributing to osteoarthritis in the hand and hip. He has pioneered the integration of finite element modeling with simulations on cadaver specimens to predict the failure mechanisms and thereby evaluate knee, hip, and most recently spinal prostheses. He continues to work closely with numerous orthopedic device manufacturers on the design and evaluation of novel implants with increased durability and reliability. Professor Hillberry very recently retired from Purdue, and plans on spending his time sailing with family.

Congratulations to all three of Purdue’s latest AIMBE Fellows!

Content copyright Purdue University and the individual authors. Comments become the property of Purdue and may be altered, edited, deleted, and used by Purdue or its agents without restriction or recompense.